• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT COBE SPECTRA BLOOD COLLECTION; COBE SPECTRA RBCX SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT COBE SPECTRA BLOOD COLLECTION; COBE SPECTRA RBCX SET Back to Search Results
Catalog Number 000000000000070700
Device Problem Fluid/Blood Leak (1250)
Patient Problems Headache (1880); Pain (1994); Pulmonary Edema (2020); Ventilator Dependent (2395); Blood Loss (2597); Test Result (2695)
Event Date 05/23/2015
Event Type  Injury  
Manufacturer Narrative
Med watch report #: (b)(4) for event codes provided by the user facility in (anemia) - anemia is not specifically addressed in the device labeling.(headache) - headache is listed as a known possible patient reaction during apheresis in the cobe spectra essentials guide- (pain) - pain is not specifically addressed in the device labeling.(ifu issue) ifus are available with each spectra device and can also be obtained on line.Ifus specify which disposable set to use for each procedure being performed.(incorrect product used) - ifus specify which disposable set to use for each procedure being performed.Additional evaluation method code used: sterilization process review investigation: fresh frozen plasma was used as a replacement fluid.3231ml replacement fluid was used, 2677 was removed from the patient, and fluid balance was 554ml.All spectra procedures use a confirmatory screen at the beginning of prime that states what disposable was entered.During run, the procedure type is displayed in the corner of the screen.Also, the data entry screens are different for each type of procedure, making mistakes more obvious.A service call was placed and a full machine checkout was performed.The machine is functioning per manufacturers specification.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.Root cause: the cause, as described by the customer, was an incorrect set used by the operator.Additional information: follow up with the customer was performed.The customer now requires a second associate to confirm and sign thereby stating that the correct kit has been chosen for the procedure.
 
Event Description
The customer reported that a red blood cell exchange (rbcx) disposable set was inadvertently used for a therapeutic plasma exchange (tpe) procedure.At 20 minutes into the procedure, blood was noticed in the collection bag.The treatment was paused and the attending physician was consulted.The physician stated that it was part of the disease process.The treatment was continued and approximately two hours later, the patient began to complain of a headache and back pain.The procedure was paused and the physician was called.Per physician's order, the procedure was stopped and post complete blood count (cbc) was performed.Test results shown the patient's hemoglobin level was 2.3g/dl.The patient was transfused with four units of packed red blood cells (prbc).The patient went into pulmonary edema and was transferred to icu and was placed a ventilator.The patient received dialysis for fluid removal and was extubated after dialysis.The patient was moved back to a regular room and daily dialysis and apheresis treatments were continued.The patient is reported to be in stable condition.The disposable set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Corrective and preventive action: an internal capa has been initiated to address user interface issue of using an incorrect disposable set for a procedure.
 
Manufacturer Narrative
This record was identified during a retrospective review of mdr's, per fda request, to identify records in which a serious injury or medical intervention occurred, but the type of reportable event was not indicated as a serious injury in the mdr form.This supplement is being filed to modify information per fda request.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBE SPECTRA BLOOD COLLECTION
Type of Device
COBE SPECTRA RBCX SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
glenda o'neill
10810 w. collins ave
lakewood, CO 80215
3032314051
MDR Report Key4913417
MDR Text Key22527733
Report Number1722028-2015-00253
Device Sequence Number1
Product Code GKT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK080035
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other,use
Reporter Occupation Health Professional
Type of Report Followup
Report Date 06/19/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/01/2017
Device Catalogue Number000000000000070700
Device Lot Number01W15262
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received07/14/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/10/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/20/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age52 YR
Patient Weight74
-
-